Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase 3 study evaluating fecal microbiota transplantation as a relapse-relief strategy in Crohn's disease after withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Crohn Disease | Phase 3 | Status: RECRUITING